Ping Yi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ping Yi has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Mingsheng Tan
Department of Orthopaedics
7 shared publications - Gong Long
Department of Preserved Knee Surgery, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China
5 shared publications Xiangsheng Tang
Department of Spine Surgery, China-Japan Friendship Hospital
5 shared publications- Zhencheng Xiong
Department of Spine Surgery
5 shared publications - Chi Zhang
Department of Orthopedics, Peking University International Hospital, Beijing, China
3 shared publications Chang Liang
College of Mechanical and Electrical Engineering, Beijing University of Chemical Technology
2 shared publications
Latest Publications
- Open Access
- 27 May 2025
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 20 (1) , 1-15
Efficacy and safety of three-dimensional printing technology assisted open reduction and internal fixation versus conventional surgery in the treatment of acetabular fractures: a meta-analysis of randomized controlled trials
The objective of this meta-analysis was to assess the influence of three-dimensional (3D) printing technology on open reduction and internal fixation (ORIF) of acetabular fractures from current randomized controlled trials (RCTs). A structured meta-analysis was conducted, and we searched online databases for published RCTs related to 3D printing and acetabular fracture, including PubMed, Cochrane Library, ScienceDirect, Wan fang, and CNKI up to November 2024. The outcome data of intraoperative blood loss, operation time, hip function (Harris score), quality of fracture reduction (Matta score) and incidence of complications were extracted. Stata16.0 and RevMan5.3 were used for our meta-analysis. 19 RCTs met our inclusion criteria and a total of 1046 patients were included in this meta-analysis. The meta-analysis showed significant difference in intraoperative blood loss (WMD = -274.65, 95% CI [-326.47, -222.83]), operation time (WMD = -53.26, 95% CI [-63.72, -42.80]), intraoperative fluoroscopy (WMD = -5.24, 95% CI [-6.57, -3.91]), instrumentation time (WMD = -35.31, 95% CI [-53.42, -17.21]), and post-surgery Matta score (RR = 1.17, 95% CI [1.09, 1.25]), incidence rate of complications (RR = 0.34, 95%CI [0.22, 0.52]). There is no significant difference in time from injury to operation (WMD=-0.06, 95%CI [-0.36, 0.24]) and Harris score (RR = 1.22, 95%CI [0.83, 1.79]) between two groups. 3D printing group showed reduced intraoperative blood loss, shorter operation time, faster instrumentation, less intraoperative fluoroscopy, better post-surgery reduction, and reduced incidence rate of complications. Therefore, based on existing research, ORIF guided by 3D printing technology should be a more effective method for treating acetabular fractures.
- 27 May 2025
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 20 (1) , 1-15
Open AccessEfficacy and safety of three-dimensional printing technology assisted open reduction and internal fixation versus conventional surgery in the treatment of acetabular fractures: a meta-analysis of randomized controlled trials
The objective of this meta-analysis was to assess the influence of three-dimensional (3D) printing technology on open reduction and internal fixation (ORIF) of acetabular fractures from current randomized controlled trials (RCTs). A structured meta-analysis was conducted, and we searched online databases for published RCTs related to 3D printing and acetabular fracture, including PubMed, Cochrane Library, ScienceDirect, Wan fang, and CNKI up to November 2024. The outcome data of intraoperative blood loss, operation time, hip function (Harris score), quality of fracture reduction (Matta score) and incidence of complications were extracted. Stata16.0 and RevMan5.3 were used for our meta-analysis. 19 RCTs met our inclusion criteria and a total of 1046 patients were included in this meta-analysis. The meta-analysis showed significant difference in intraoperative blood loss (WMD = -274.65, 95% CI [-326.47, -222.83]), operation time (WMD = -53.26, 95% CI [-63.72, -42.80]), intraoperative fluoroscopy (WMD = -5.24, 95% CI [-6.57, -3.91]), instrumentation time (WMD = -35.31, 95% CI [-53.42, -17.21]), and post-surgery Matta score (RR = 1.17, 95% CI [1.09, 1.25]), incidence rate of complications (RR = 0.34, 95%CI [0.22, 0.52]). There is no significant difference in time from injury to operation (WMD=-0.06, 95%CI [-0.36, 0.24]) and Harris score (RR = 1.22, 95%CI [0.83, 1.79]) between two groups. 3D printing group showed reduced intraoperative blood loss, shorter operation time, faster instrumentation, less intraoperative fluoroscopy, better post-surgery reduction, and reduced incidence rate of complications. Therefore, based on existing research, ORIF guided by 3D printing technology should be a more effective method for treating acetabular fractures.
- 19 January 2024
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 203,p. e66247
Biomechanical Analysis of Adjacent Segments after Spinal Fusion Surgery Using a Geometrically Parametric Patient-Specific Finite Element Model
This study aimed to perform a mechanical analysis of adjacent segments after spinal fusion surgery using a geometrically parametric patient-specific finite element model to elucidate the mechanism of adjacent segment degeneration (ASD), thereby providing theoretical evidence for early disease prevention. Fourteen parameters based on patient-specific spinal geometry were extracted from a patient's preoperative computed tomography (CT) scan, and the relative positions of each spinal segment were determined using the image match method. A preoperative patient-specific model of the spine was established through the above method. The postoperative model after L4-L5 posterior lumbar interbody fusion (PLIF) surgery was constructed using the same method except that the lamina and intervertebral disc were removed, and a cage, 4 pedicle screws, and 2 connecting rods were inserted. Range of motion (ROM) and stress changes were determined by comparing the values of each anatomical structure between the preoperative and postoperative models. The overall ROM of the lumbar spine decreased after fusion, while the ROM, stress in the facet joints, and stress in the intervertebral disc of adjacent segments all increased. An analysis of the stress distribution in the annulus fibrosus, nucleus pulposus, and facet joints also showed that not only was the maximum stress in these tissues elevated, but the areas of moderate-to-high stress were also expanded. During torsion, the stress in the facet joints and annulus fibrosus of the proximal adjacent segment (L3-L4) increased to a larger extent than that in the distal adjacent segment (L5-S1). While fusion surgery causes an overall restriction of motion in the lumbar spine, it also causes more load sharing by the adjacent segments to compensate for the fused segment, thus increasing the risk of ASD. The proximal adjacent segment is more prone to degeneration than the distal adjacent segment after spinal fusion due to the significant increase in stress.
- 19 January 2024
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 203,p. e66247
Biomechanical Analysis of Adjacent Segments after Spinal Fusion Surgery Using a Geometrically Parametric Patient-Specific Finite Element Model
This study aimed to perform a mechanical analysis of adjacent segments after spinal fusion surgery using a geometrically parametric patient-specific finite element model to elucidate the mechanism of adjacent segment degeneration (ASD), thereby providing theoretical evidence for early disease prevention. Fourteen parameters based on patient-specific spinal geometry were extracted from a patient's preoperative computed tomography (CT) scan, and the relative positions of each spinal segment were determined using the image match method. A preoperative patient-specific model of the spine was established through the above method. The postoperative model after L4-L5 posterior lumbar interbody fusion (PLIF) surgery was constructed using the same method except that the lamina and intervertebral disc were removed, and a cage, 4 pedicle screws, and 2 connecting rods were inserted. Range of motion (ROM) and stress changes were determined by comparing the values of each anatomical structure between the preoperative and postoperative models. The overall ROM of the lumbar spine decreased after fusion, while the ROM, stress in the facet joints, and stress in the intervertebral disc of adjacent segments all increased. An analysis of the stress distribution in the annulus fibrosus, nucleus pulposus, and facet joints also showed that not only was the maximum stress in these tissues elevated, but the areas of moderate-to-high stress were also expanded. During torsion, the stress in the facet joints and annulus fibrosus of the proximal adjacent segment (L3-L4) increased to a larger extent than that in the distal adjacent segment (L5-S1). While fusion surgery causes an overall restriction of motion in the lumbar spine, it also causes more load sharing by the adjacent segments to compensate for the fused segment, thus increasing the risk of ASD. The proximal adjacent segment is more prone to degeneration than the distal adjacent segment after spinal fusion due to the significant increase in stress.
- Open Access
- 3 May 2023
- Published by Wiley in Clinical Pharmacology in Drug Development
- Vol. 12 (6) , 553-571
Disposition and Mass Balance of Etrasimod in Healthy Subjects and In Vitro Determination of the Enzymes Responsible for Its Oxidative Metabolism
Etrasimod (APD334) is an investigational, once‐daily, oral, selective sphingosine 1‐phosphate receptor 1,4,5 modulator (S1P1,4,5) in development for treatment of various immune‐mediated inflammatory disorders. The disposition and mass balance of a single 2‐mg [14C]etrasimod dose were evaluated in 8 healthy males. An in vitro study was also conducted to identify etrasimod's oxidative metabolizing enzymes. Peak concentrations of etrasimod and total radioactivity in plasma and whole blood were typically reached 4–7 hours postdose. Etrasimod constituted 49.3% of total radioactivity plasma exposure, with multiple minor/trace metabolites making up the remainder. Etrasimod was slowly cleared mainly via biotransformation, predominantly by oxidative metabolism, with unchanged etrasimod recovered in feces accounting for only 11.2% of the dose and none in urine. The mean apparent terminal half‐lives of etrasimod and total radioactivity in plasma were 37.8 and 89.0 hours, respectively. Mean cumulative recovery of radioactivity in excreta over 336 hours was 86.9% of the dose, mostly in feces. The prevalent metabolites eliminated in feces were M3 (hydroxy‐etrasimod) and M36 (oxy‐etrasimod sulfate), accounting for 22.1% and 18.9% of the dose, respectively. From in vitro reaction phenotyping, the predominant enzymes involved in the oxidation of etrasimod were CYP2C8, CYP2C9, and CYP3A4, with minor contributions from CYP2C19 and CYP2J2.
- 3 May 2023
- Published by Wiley in Clinical Pharmacology in Drug Development
- Vol. 12 (6) , 553-571
Open AccessDisposition and Mass Balance of Etrasimod in Healthy Subjects and In Vitro Determination of the Enzymes Responsible for Its Oxidative Metabolism
Etrasimod (APD334) is an investigational, once‐daily, oral, selective sphingosine 1‐phosphate receptor 1,4,5 modulator (S1P1,4,5) in development for treatment of various immune‐mediated inflammatory disorders. The disposition and mass balance of a single 2‐mg [14C]etrasimod dose were evaluated in 8 healthy males. An in vitro study was also conducted to identify etrasimod's oxidative metabolizing enzymes. Peak concentrations of etrasimod and total radioactivity in plasma and whole blood were typically reached 4–7 hours postdose. Etrasimod constituted 49.3% of total radioactivity plasma exposure, with multiple minor/trace metabolites making up the remainder. Etrasimod was slowly cleared mainly via biotransformation, predominantly by oxidative metabolism, with unchanged etrasimod recovered in feces accounting for only 11.2% of the dose and none in urine. The mean apparent terminal half‐lives of etrasimod and total radioactivity in plasma were 37.8 and 89.0 hours, respectively. Mean cumulative recovery of radioactivity in excreta over 336 hours was 86.9% of the dose, mostly in feces. The prevalent metabolites eliminated in feces were M3 (hydroxy‐etrasimod) and M36 (oxy‐etrasimod sulfate), accounting for 22.1% and 18.9% of the dose, respectively. From in vitro reaction phenotyping, the predominant enzymes involved in the oxidation of etrasimod were CYP2C8, CYP2C9, and CYP3A4, with minor contributions from CYP2C19 and CYP2J2.
- Open Access
- 28 December 2022
- Published by Springer Nature in Research Square
Biomechanical analysis of adjacent segments after spine fusion surgery using a novel geometrically-parametric patient-specific finite element model
OBJECTIVE: This study aimed to perform mechanical analysis of adjacent segments after spine fusion surgery using a novel geometrically-parametric patient-specific finite element model and to elucidate the mechanism of adjacent segments degeneration(ASD)thus providing theoretical evidence for early prevention. METHODS: Fourteen parameters based on patient specific spinal geometry were extracted from the patient's preoperative computed tomography(CT), and the relative positions of each spinal segment were determined using image match method. A preoperative patient-specific model of spine was established by the above method. The postoperative model of L45 posterior lumbar interbody fusion(PLIF) surgery was constructed using the same method except for removing the lamina and the intervebral disc, and inserting a cage, 4 pedicle screws, and 2 connecting rods. Range of motion(ROM) and stress changes were compared between each anatomic structure of the preoperative and postoperative models. RESULTS: The overall ROM of the lumbar spine decreased after fusion, while the ROM, stress at facet joint, and stress at the intervertebral disc of adjacent segments all increased. The stress distribution in the annulus fibrosus, nucleus pulposus, and facet joints also showed that not only the maximum stress in these tissues were elevated, but the areas of the moderate-to-high stress region were also expanded. During torsion, the stress at facet joint and annulus fibrosus of the proximal adjacent segment (L34) increased to a larger extent compared with the distal adjacent segment (L5S1). Conclusion: While fusion surgery causes an overall restriction of motion at the lumbar spine, it also causes more loads sharing by the adjacent segments in order to compensate for the fused segment, thus increasing the risk of ASD. The proximal adjacent segment is more prone to degeneration than the distal adjacent segment after spinal fusion due to the significant increase in stress changes.
- 28 December 2022
- Published by Springer Nature in Research Square
Open AccessBiomechanical analysis of adjacent segments after spine fusion surgery using a novel geometrically-parametric patient-specific finite element model
OBJECTIVE: This study aimed to perform mechanical analysis of adjacent segments after spine fusion surgery using a novel geometrically-parametric patient-specific finite element model and to elucidate the mechanism of adjacent segments degeneration(ASD)thus providing theoretical evidence for early prevention. METHODS: Fourteen parameters based on patient specific spinal geometry were extracted from the patient's preoperative computed tomography(CT), and the relative positions of each spinal segment were determined using image match method. A preoperative patient-specific model of spine was established by the above method. The postoperative model of L45 posterior lumbar interbody fusion(PLIF) surgery was constructed using the same method except for removing the lamina and the intervebral disc, and inserting a cage, 4 pedicle screws, and 2 connecting rods. Range of motion(ROM) and stress changes were compared between each anatomic structure of the preoperative and postoperative models. RESULTS: The overall ROM of the lumbar spine decreased after fusion, while the ROM, stress at facet joint, and stress at the intervertebral disc of adjacent segments all increased. The stress distribution in the annulus fibrosus, nucleus pulposus, and facet joints also showed that not only the maximum stress in these tissues were elevated, but the areas of the moderate-to-high stress region were also expanded. During torsion, the stress at facet joint and annulus fibrosus of the proximal adjacent segment (L34) increased to a larger extent compared with the distal adjacent segment (L5S1). Conclusion: While fusion surgery causes an overall restriction of motion at the lumbar spine, it also causes more loads sharing by the adjacent segments in order to compensate for the fused segment, thus increasing the risk of ASD. The proximal adjacent segment is more prone to degeneration than the distal adjacent segment after spinal fusion due to the significant increase in stress changes.
- 1 March 2022
- Published by Elsevier in Journal of Orthopaedic Science
- Vol. 27 (2) , 342-347
Generalized joint laxity as a predictor of recovering from low back pain during pregnancy – A prospective study
- 1 March 2022
- Published by Elsevier in Journal of Orthopaedic Science
- Vol. 27 (2) , 342-347
Generalized joint laxity as a predictor of recovering from low back pain during pregnancy – A prospective study
- Open Access
- 1 January 2022
- Published by Wiley in BioMed Research International
- Vol. 2022 (1) , 6747469
Meta‐Analysis of the Efficacy and Safety of Alendronate Combined with Atorvastatin in the Treatment of Osteoporosis in Diabetes Mellitus
Objective. Diabetes is a chronic disease caused by defective insulin secretion in the body, resulting in metabolic abnormalities with persistent blood glucose elevation. Osteoporosis is the most common diabetes complication. The aim of this study was to perform a meta‐analysis of the effects of alendronate combined with atorvastatin compared with alendronate alone in the treatment of osteoporosis in diabetes mellitus. Methods. Two researchers independently used PubMed, ScienceDirect, Cochrane Library, Wanfang Data, CNKI, and VIP databases to search for all relevant studies that met the inclusion criteria and used RevMan 5.3 and STATA 16.0 for data analysis. Results. Fourteen studies that met the inclusion criteria were selected, including 1456 patients. Among the data extracted in this meta‐analysis, bone mineral density (BMD) was the primary outcome measurement, while total effective rate, VAS, osteoprotegerin (OPG), bone Gla protein (BGP), bone alkaline phosphatase (BAP), blood P and Ca, and adverse effects were secondary outcome measurements. Our results showed that alendronate combined with atorvastatin is more effective than alendronate alone, with higher BMD, OPG, BGP, and BAP, more significant pain relief, and fewer adverse events. Conclusion. The results of this meta‐analysis indicate that alendronate combined with atorvastatin is a better treatment for osteoporosis in diabetes mellitus, showing more effective and higher BMD and fewer adverse events than alendronate alone.
- 1 January 2022
- Published by Wiley in BioMed Research International
- Vol. 2022 (1) , 6747469
Open AccessMeta‐Analysis of the Efficacy and Safety of Alendronate Combined with Atorvastatin in the Treatment of Osteoporosis in Diabetes Mellitus
Objective. Diabetes is a chronic disease caused by defective insulin secretion in the body, resulting in metabolic abnormalities with persistent blood glucose elevation. Osteoporosis is the most common diabetes complication. The aim of this study was to perform a meta‐analysis of the effects of alendronate combined with atorvastatin compared with alendronate alone in the treatment of osteoporosis in diabetes mellitus. Methods. Two researchers independently used PubMed, ScienceDirect, Cochrane Library, Wanfang Data, CNKI, and VIP databases to search for all relevant studies that met the inclusion criteria and used RevMan 5.3 and STATA 16.0 for data analysis. Results. Fourteen studies that met the inclusion criteria were selected, including 1456 patients. Among the data extracted in this meta‐analysis, bone mineral density (BMD) was the primary outcome measurement, while total effective rate, VAS, osteoprotegerin (OPG), bone Gla protein (BGP), bone alkaline phosphatase (BAP), blood P and Ca, and adverse effects were secondary outcome measurements. Our results showed that alendronate combined with atorvastatin is more effective than alendronate alone, with higher BMD, OPG, BGP, and BAP, more significant pain relief, and fewer adverse events. Conclusion. The results of this meta‐analysis indicate that alendronate combined with atorvastatin is a better treatment for osteoporosis in diabetes mellitus, showing more effective and higher BMD and fewer adverse events than alendronate alone.
- 6 November 2021
- Published by Springer Nature in European Spine Journal
- Vol. 31 (2) , 288-300
The retropharyngeal steroid use during operation on the fusion rate and dysphagia after ACDF? A systematic review and meta-analysis
Purpose The aim of this meta-analysis was to investigate the effects of retropharyngeal steroid use during operation on bony fusion and dysphagia rate after ACDF. Methods We searched the electronic literature database of PubMed, Embase and the Cochrane Library published from January 1990 to February 2020. The size of each group, mean age, proportion of female patients, dysphagia events and fusion rate at one-year follow-up were extracted. RevMan 5.3 was used for the meta-analysis. Results A total of eight studies including six RCTs and two case–control studies met the inclusion criteria. This meta-analysis showed that retropharyngeal steroids could achieve significantly lower dysphagia rates (p < 0.001), higher fusion rates (p = 0.01), less moderate and severe events rates according to the Bazaz stratification (p < 0.001). However, there was no significant difference between two groups regarding operation time (p = 0.67), blood loss (p = 0.33), VAS scores at one day (p = 0.90) and VAS scores at two weeks (p = 0.80). Conclusions Retropharyngeal steroid use is an effective method in reducing dysphagia rate, severe dysphagia rate and increasing fusion rate during ACDF surgery, without increasing operating time, blood loss or VAS scores at one day and two weeks. Level of Evidence I Diagnostic: individual cross-sectional studies with the consistently applied reference standard and blinding.
- 6 November 2021
- Published by Springer Nature in European Spine Journal
- Vol. 31 (2) , 288-300
The retropharyngeal steroid use during operation on the fusion rate and dysphagia after ACDF? A systematic review and meta-analysis
Purpose The aim of this meta-analysis was to investigate the effects of retropharyngeal steroid use during operation on bony fusion and dysphagia rate after ACDF. Methods We searched the electronic literature database of PubMed, Embase and the Cochrane Library published from January 1990 to February 2020. The size of each group, mean age, proportion of female patients, dysphagia events and fusion rate at one-year follow-up were extracted. RevMan 5.3 was used for the meta-analysis. Results A total of eight studies including six RCTs and two case–control studies met the inclusion criteria. This meta-analysis showed that retropharyngeal steroids could achieve significantly lower dysphagia rates (p < 0.001), higher fusion rates (p = 0.01), less moderate and severe events rates according to the Bazaz stratification (p < 0.001). However, there was no significant difference between two groups regarding operation time (p = 0.67), blood loss (p = 0.33), VAS scores at one day (p = 0.90) and VAS scores at two weeks (p = 0.80). Conclusions Retropharyngeal steroid use is an effective method in reducing dysphagia rate, severe dysphagia rate and increasing fusion rate during ACDF surgery, without increasing operating time, blood loss or VAS scores at one day and two weeks. Level of Evidence I Diagnostic: individual cross-sectional studies with the consistently applied reference standard and blinding.
- Open Access
- 10 August 2021
- Published by Wiley in Stem Cells International
- Vol. 2021, 1-18
Evaluation of the Efficacy of Stem Cell Therapy in Ovariectomized Osteoporotic Rats Based on Micro-CT and Dual-Energy X-Ray Absorptiometry: A Systematic Review and Meta-Analysis
Objective. Osteoporosis is an abnormal bone metabolism disease characterized by microstructural degeneration of bone tissue and reduction in bone mass, resulting in increased brittleness of bone tissue and susceptibility to fracture. Due to the tissue regenerative potential of stem cell transplantation, it is now used in the treatment of various disease models such as osteoporosis. The purpose of this work is to carry out a systematic review and meta-analysis of the efficacy of stem cell therapy in ovariectomized (OVX) osteoporotic rats. Methods. PubMed, Cochrane Library, ScienceDirect, Embase, CNKI, and Wanfang Databases were used to search for articles that met the inclusion criteria. Two researchers independently screened the articles that met the inclusion criteria. RevMan 5.3 and STATA 16.0 were used for data analysis. This meta-analysis was registered at INPLASY with reference number ID: INPLASY202150017. Results. Thirteen eligible studies were selected, including 405 rats. The sources of stem cells are divided into four main categories: bone marrow mesenchymal stem cells (BMSCs), adipose-derived stem cells (ADSCs), amniotic membrane mesenchymal stem cells (AM-MSCs), and human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs). Compared with the OVX group, both stem cell transplantation groups had higher bone mineral density (BMD) (BMSCs: , 95% CI: [1.38, 2.63], , ; ADSCs: , 95% CI: [0.79, 3.69], , ) and bone volume/total volume (BV/TV) (hUCB-MSCs: , 95% CI: [0.97, 2.44], , ; ADSCs: , 95% CI: [0.27, 4.04], , ). In the BMSC treatment groups, the trabecular numbers (Tb.N) ( , 95% CI: [0.91, 7.64], <svg xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/2000/svg" width="19.289pt" style="vertical-align:-0.2064009pt" id="M14"...
- 10 August 2021
- Published by Wiley in Stem Cells International
- Vol. 2021, 1-18
Open AccessEvaluation of the Efficacy of Stem Cell Therapy in Ovariectomized Osteoporotic Rats Based on Micro-CT and Dual-Energy X-Ray Absorptiometry: A Systematic Review and Meta-Analysis
Objective. Osteoporosis is an abnormal bone metabolism disease characterized by microstructural degeneration of bone tissue and reduction in bone mass, resulting in increased brittleness of bone tissue and susceptibility to fracture. Due to the tissue regenerative potential of stem cell transplantation, it is now used in the treatment of various disease models such as osteoporosis. The purpose of this work is to carry out a systematic review and meta-analysis of the efficacy of stem cell therapy in ovariectomized (OVX) osteoporotic rats. Methods. PubMed, Cochrane Library, ScienceDirect, Embase, CNKI, and Wanfang Databases were used to search for articles that met the inclusion criteria. Two researchers independently screened the articles that met the inclusion criteria. RevMan 5.3 and STATA 16.0 were used for data analysis. This meta-analysis was registered at INPLASY with reference number ID: INPLASY202150017. Results. Thirteen eligible studies were selected, including 405 rats. The sources of stem cells are divided into four main categories: bone marrow mesenchymal stem cells (BMSCs), adipose-derived stem cells (ADSCs), amniotic membrane mesenchymal stem cells (AM-MSCs), and human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs). Compared with the OVX group, both stem cell transplantation groups had higher bone mineral density (BMD) (BMSCs: , 95% CI: [1.38, 2.63], , ; ADSCs: , 95% CI: [0.79, 3.69], , ) and bone volume/total volume (BV/TV) (hUCB-MSCs: , 95% CI: [0.97, 2.44], , ; ADSCs: , 95% CI: [0.27, 4.04], , ). In the BMSC treatment groups, the trabecular numbers (Tb.N) ( , 95% CI: [0.91, 7.64], <svg xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/2000/svg" width="19.289pt" style="vertical-align:-0.2064009pt" id="M14"...
- Open Access
- 22 April 2021
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2021, 1-20
Deciphering Pharmacological Mechanism of Buyang Huanwu Decoction for Spinal Cord Injury by Network Pharmacology Approach
Objective. The purpose of this study was to investigate the mechanism of action of the Chinese herbal formula Buyang Huanwu Decoction (BYHWD), which is commonly used to treat nerve injuries, in the treatment of spinal cord injury (SCI) using a network pharmacology method. Methods. BYHWD-related targets were obtained by mining the TCMSP and BATMAN-TCM databases, and SCI-related targets were obtained by mining the DisGeNET, TTD, CTD, GeneCards, and MalaCards databases. The overlapping targets of the abovementioned targets may be potential therapeutic targets for BYHWD anti-SCI. Subsequently, we performed protein-protein interaction (PPI) analysis, screened the hub genes using Cytoscape software, performed Gene Ontology (GO) annotation and KEGG pathway enrichment analysis, and finally achieved molecular docking between the hub proteins and key active compounds. Results. The 189 potential therapeutic targets for BYHWD anti-SCI were overlapping targets of 744 BYHWD-related targets and 923 SCI-related targets. The top 10 genes obtained subsequently included AKT1, IL6, MAPK1, TNF, TP53, VEGFA, CASP3, ALB, MAPK8, and JUN. Fifteen signaling pathways were also screened out after enrichment analysis and literature search. The results of molecular docking of key active compounds and hub target proteins showed a good binding affinity for both. Conclusion. This study shows that BYHWD anti-SCI is characterized by a multicomponent, multitarget, and multipathway synergy and provides new insights to explore the specific mechanisms of BYHWD against SCI.
- 22 April 2021
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2021, 1-20
Open AccessDeciphering Pharmacological Mechanism of Buyang Huanwu Decoction for Spinal Cord Injury by Network Pharmacology Approach
Objective. The purpose of this study was to investigate the mechanism of action of the Chinese herbal formula Buyang Huanwu Decoction (BYHWD), which is commonly used to treat nerve injuries, in the treatment of spinal cord injury (SCI) using a network pharmacology method. Methods. BYHWD-related targets were obtained by mining the TCMSP and BATMAN-TCM databases, and SCI-related targets were obtained by mining the DisGeNET, TTD, CTD, GeneCards, and MalaCards databases. The overlapping targets of the abovementioned targets may be potential therapeutic targets for BYHWD anti-SCI. Subsequently, we performed protein-protein interaction (PPI) analysis, screened the hub genes using Cytoscape software, performed Gene Ontology (GO) annotation and KEGG pathway enrichment analysis, and finally achieved molecular docking between the hub proteins and key active compounds. Results. The 189 potential therapeutic targets for BYHWD anti-SCI were overlapping targets of 744 BYHWD-related targets and 923 SCI-related targets. The top 10 genes obtained subsequently included AKT1, IL6, MAPK1, TNF, TP53, VEGFA, CASP3, ALB, MAPK8, and JUN. Fifteen signaling pathways were also screened out after enrichment analysis and literature search. The results of molecular docking of key active compounds and hub target proteins showed a good binding affinity for both. Conclusion. This study shows that BYHWD anti-SCI is characterized by a multicomponent, multitarget, and multipathway synergy and provides new insights to explore the specific mechanisms of BYHWD against SCI.
- Open Access
- 4 April 2021
- Published by Wiley in Orthopaedic Surgery
- Vol. 13 (3) , 932-941
Subclinical Hypothyroidism Affects Postoperative Outcome of Patients Undergoing Total Knee Arthroplasty
Objective: The aim of this study was to investigate whether subclinical hypothyroidism could increase the risk of postoperative complications in patients undergoing primary total knee arthroplasty (TKA).Methods: A prospective case‐control study of 796 patients undergoing primary TKA between January 2015 and January 2020 was performed. A total of 700 patients (87.9%) were female and the average age of included patients was 65.0 years, with a standard deviation of 5.6. The participants who had subclinical hypothyroidism were referred to as the case group, while those without abnormal thyrotropin (TSH) were included in the control group (matched for age and gender). The fasting plasma levels of TSH were tested in the morning in all patients. The diagnosis of subclinical hypothyroidism was completed by a senior endocrinologist based on laboratory tests; namely, a serum TSH ≥ 5 mu/L and normal free thyroxine (FT4). Subclinical hypothyroidism was further described as mild (TSH < 10 mu/L) or severe (TSH ≥ 10 mu/L). The incidence of 90‐day postoperative complications was compared between two cohorts. Logistic regression analysis was used for the risk factors of 90‐day postoperative complications following TKA.Results: A total of 398 patients had a diagnosis of subclinical hypothyroidism. Among them, 275 cases (69.1%) were described as mild (79 patients [19.8%] with low FT4 and 196 patients [49.2%] with normal FT4 in the repeated test) and 123 cases (30.9%) as severe subclinical hypothyroidism. Of the 196 patients (49.2%) with mild subclinical hypothyroidism and normal FT4, 63 patients (15.8%) had symptoms before surgery. Patients were followed up for an average duration of 25.4 months (6 to 43 months). A total of 265 patients (66.6%) received preoperative treatment for subclinical hypothyroidism, with an average therapy time of 9.2 months. There were 162 patients (40.7%) with positive autoantibodies to thyroid peroxidase (anti‐TPO). There were no statistically significant differences in baseline data between cohorts (all P > 0.05). As for the cumulative 90‐day outcomes, subclinical hypothyroidism increased the incidences of both medical and surgical complications following primary TKA compared to those without this condition (11.6% vs 7.2%, OR = 1.55, 95% confidence interval [CI] = 1.47–1.62, P < 0.05). Subclinical hypothyroidism caused patients to suffer increased total incidence of readmission within the first 90 days after discharge when compared to those without this condition (20.61% vs 14.15%, OR = 1.45, 95% CI = 1.41–1.49, P < 0.001). Controlling for preoperative and intraoperative variables, the patients with TSH ≥ 10 mu/L and positive anti‐TPO and those without corrected subclinical hypothyroid and thyroid hormone supplementation were more likely to experience postoperative complications within 90 days of TKA.Conclusion: Subclinical hypothyroidism might increase the risk of postoperative complications within 90 days of TKA, especially for the patients with TSH ≥ 10 mu/L and positive anti‐TPO and those without corrected subclinical hypothyroid and thyroid hormone supplementation.
- 4 April 2021
- Published by Wiley in Orthopaedic Surgery
- Vol. 13 (3) , 932-941
Open AccessSubclinical Hypothyroidism Affects Postoperative Outcome of Patients Undergoing Total Knee Arthroplasty
Objective: The aim of this study was to investigate whether subclinical hypothyroidism could increase the risk of postoperative complications in patients undergoing primary total knee arthroplasty (TKA).Methods: A prospective case‐control study of 796 patients undergoing primary TKA between January 2015 and January 2020 was performed. A total of 700 patients (87.9%) were female and the average age of included patients was 65.0 years, with a standard deviation of 5.6. The participants who had subclinical hypothyroidism were referred to as the case group, while those without abnormal thyrotropin (TSH) were included in the control group (matched for age and gender). The fasting plasma levels of TSH were tested in the morning in all patients. The diagnosis of subclinical hypothyroidism was completed by a senior endocrinologist based on laboratory tests; namely, a serum TSH ≥ 5 mu/L and normal free thyroxine (FT4). Subclinical hypothyroidism was further described as mild (TSH < 10 mu/L) or severe (TSH ≥ 10 mu/L). The incidence of 90‐day postoperative complications was compared between two cohorts. Logistic regression analysis was used for the risk factors of 90‐day postoperative complications following TKA.Results: A total of 398 patients had a diagnosis of subclinical hypothyroidism. Among them, 275 cases (69.1%) were described as mild (79 patients [19.8%] with low FT4 and 196 patients [49.2%] with normal FT4 in the repeated test) and 123 cases (30.9%) as severe subclinical hypothyroidism. Of the 196 patients (49.2%) with mild subclinical hypothyroidism and normal FT4, 63 patients (15.8%) had symptoms before surgery. Patients were followed up for an average duration of 25.4 months (6 to 43 months). A total of 265 patients (66.6%) received preoperative treatment for subclinical hypothyroidism, with an average therapy time of 9.2 months. There were 162 patients (40.7%) with positive autoantibodies to thyroid peroxidase (anti‐TPO). There were no statistically significant differences in baseline data between cohorts (all P > 0.05). As for the cumulative 90‐day outcomes, subclinical hypothyroidism increased the incidences of both medical and surgical complications following primary TKA compared to those without this condition (11.6% vs 7.2%, OR = 1.55, 95% confidence interval [CI] = 1.47–1.62, P < 0.05). Subclinical hypothyroidism caused patients to suffer increased total incidence of readmission within the first 90 days after discharge when compared to those without this condition (20.61% vs 14.15%, OR = 1.45, 95% CI = 1.41–1.49, P < 0.001). Controlling for preoperative and intraoperative variables, the patients with TSH ≥ 10 mu/L and positive anti‐TPO and those without corrected subclinical hypothyroid and thyroid hormone supplementation were more likely to experience postoperative complications within 90 days of TKA.Conclusion: Subclinical hypothyroidism might increase the risk of postoperative complications within 90 days of TKA, especially for the patients with TSH ≥ 10 mu/L and positive anti‐TPO and those without corrected subclinical hypothyroid and thyroid hormone supplementation.